Metraipolis › archive › dc_91db2c610281

Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a… — Europe PMC PMID:42805665

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42805665
DOI
10.1136/bmjopen-2025-112493
License (as archived)
solo-consultazione
Archived
2026-10-07T19:00:21.758Z
SHA-256 of the archived text
3ab7ab4f08e33df352038a598c8153e107ea7d2abc7caeddb6da579d994e07a8
Stable URL of this page
https://metraipolis.com/documento/dc_91db2c610281

How to cite

Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a… — Europe PMC PMID:42805665 — Europe PMC (en), https://europepmc.org/article/MED/42805665 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_91db2c610281 (Metraipolis archive dc_91db2c610281, sha256 3ab7ab4f08e33df352038a598c8153e107ea7d2abc7caeddb6da579d994e07a8)
BibTeX
@misc{dc91db2c610281,
  title = {Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a… — Europe PMC PMID:42805665},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42805665},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_91db2c610281; sha256 3ab7ab4f08e33df352038a598c8153e107ea7d2abc7caeddb6da579d994e07a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42805665. Agents can read the archived copy with the MCP tool read_document.